Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
BI-836858 by Boehringer Ingelheim International for Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia): Likelihood of Approval
BI-836858 is under clinical development by Boehringer Ingelheim International and currently in Phase II for Acute Myelocytic Leukemia (AML, Acute...
BI-836858 by Boehringer Ingelheim International for Refractory Acute Myeloid Leukemia: Likelihood of Approval
BI-836858 is under clinical development by Boehringer Ingelheim International and currently in Phase II for Refractory Acute Myeloid Leukemia. According...
BI-836858 by Boehringer Ingelheim International for Relapsed Acute Myeloid Leukemia: Likelihood of Approval
BI-836858 is under clinical development by Boehringer Ingelheim International and currently in Phase II for Relapsed Acute Myeloid Leukemia. According...